Singapore became the first Asian country to receive COVID-19 shots with the delivery of the first batch of Pfizer-BioNTech vaccines on Monday evening.
The vaccine shipment was flown from Belgium by Singapore Airlines and was received by Transport Minister Ong Ye Kung at Changi airport.
Singapore is expecting vaccines from other manufacturers on the way in the coming months, expecting to have enough for everyone by the third quarter of next year.
Singapore will make the vaccinations available for free, but getting inoculated will be voluntary.
Moderna also agreed to supply its COVID-19 vaccine to Singapore.
The city-state is about to ease the restriction it had imposed in a semi-lockdown beginning April this year.
With a population of about 5.7 million, Singapore has reported just over 58,000 cases of infection so far, with most of them occurring in migrant workers.


Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 



